glp-1 news today november 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 What the Obesity Drugmakers Expect
Pay in 4 interest-free payments of $6.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14



















![PDF] Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised](https://figures.semanticscholar.org/5816b1c59f4d4a3acfbcb163ca4cc3bae5190a23/8-Figure2-1.png)








